The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

February 2, 2022 • By Samantha C. Shapiro, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR CONVERGENCE 2021—Pulmonary disease is a potentially serious, yet oft-underdiagnosed complication of Sjögren’s syndrome. Fortunately, Consensus Guidelines for the Evaluation and Management of Pulmonary Disease in Sjögren’s were released in 2021.1 The guidelines were initiated and supported by the Sjögren’s Foundation. Pulmonologists, rheumatologists and patients worked together to finalize the document.

You Might Also Like
  • A Case Study in Sweet’s Syndrome with Pulmonary Involvement
  • Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain
  • Sjögren’s Syndrome: Beyond Dryness
Also By This Author
  • How to Help Patients with Chronic Pain

During ACR Convergence 2021, a pulmonologist and a rheumatologist, both of whom helped craft the guidelines, discussed the diagnosis and management of pulmonary manifestations of Sjögren’s syndrome.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pulmonary Manifestations of Sjögren’s Syndrome

Approximately one in six patients living with Sjögren’s syndrome has pulmonary involvement, which is associated with higher mortality and lower quality of life compared with patients with Sjogren’s syndrome who do not have pulmonary involvement. Augustine S. Lee, MD, MSc, FCCP, chair of the Division of Pulmonary Medicine, Mayo Clinic Florida, Jacksonville, reviewed common pulmonary manifestations in Sjögren’s syndrome and the recommended approach.

1. Sjögren’s syndrome with no respiratory symptoms

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Screening for pulmonary disease is of utmost importance [because] 10–20% of patients [with Sjögren’s syndrome] will have clinically relevant pulmonary involvement,” Dr. Lee said.

Screening should include a careful respiratory history, cardiopulmonary exam, a baseline chest radiograph and baseline complete pulmonary function testing (PFT; i.e., spirometry, lung volumes, diffusing capacity of the lungs for carbon monoxide [DLCO]), and resting and exercise oxygen saturation readings.

2. Sjögren’s syndrome with a cough

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In a patient with Sjögren’s syndrome who has pulmonary symptoms, the recommendation is to obtain high-resolution computed tomography (CT) of the chest—as opposed to a chest radiograph—in addition to complete PFTs.

“[A chest radiograph] may miss 10–15% of significant disorders, such as interstitial lung disease [ILD], neoplasms or bronchiolar diseases,” Dr. Lee said. “Of note, the [high-resolution CT] should include expiratory views. This is particularly important because of the potential for small airway involvement in Sjögren’s syndrome, which standard inspiratory views on the [high-resolution CT] and PFTs will not detect. Prone imaging should also be considered if needed to differentiate dependent subpleural atelectasis from ILD.”2

Dr. Lee continued, “Although evaluation for more nefarious etiologies is paramount, the most likely cause of cough in Sjögren’s syndrome remains xerotrachea. Common associations, such as gastroesophageal reflux disorder, asthma and rhinitis, should also be considered.”

3. Sjögren’s syndrome with ILD

About 25% of patients with Sjögren’s syndrome will have ILD, with nonspecific interstitial pneumonia (NSIP) being the most common subtype (45%). Fortunately, lung biopsy is typically not required for diagnosis, and treatment is based on the pattern of ILD, symptoms, degree of lung dysfunction and clinical course.3

“The guidelines provide flow-diagramed specifics,” said Dr. Lee, “but in general, patients should be monitored with PFTs and pulse oximetry. Supportive measures, such as oxygen and pulmonary rehabilitation, are important parts of therapy. I consider adding anti-fibrotics to patients with clear fibrotic patterns [e.g., usual interstitial pneumonia] or after failing or progressing despite standard anti-inflammatory therapies. Transplant should be entertained early in patients who are rapidly deteriorating or in patients with significant oxygen requirements.”

Pages: 1 2 3 4 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports Tagged With: ACR Convergence 2021, lungs, Pulmonary, Sjögren's syndrome

You Might Also Like:
  • A Case Study in Sweet’s Syndrome with Pulmonary Involvement
  • Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain
  • Sjögren’s Syndrome: Beyond Dryness
  • Catastrophic Antiphospholipid Syndrome with Pulmonary Hemorrhage: A Case Report

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)